$426.31
2.68%
Nasdaq, Oct 30, 11:29 am EDT. Market open.
ISIN
US05464C1018
Symbol
AXON

Axon Enterprise Inc Target price 2026 - Analyst rating & recommendation

Axon Enterprise Inc Classifications & Recommendation

Buy
89%
Hold
11%

Axon Enterprise Inc Price Target

Target Price $697.68
Price $438.05
Potential 59.27%
Number of Estimates 22
22 Analysts have issued a price target Axon Enterprise Inc 2027 . The average Axon Enterprise Inc target price is $697.68. This is 59.27% higher than the current stock price. The highest price target is $871.50 98.95% , the lowest is $446.73 1.98% .
A rating was issued by 28 analysts: 25 Analysts recommend Axon Enterprise Inc to buy, 3 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Axon Enterprise Inc stock has an average upside potential 2027 of 59.27% . Most analysts recommend the Axon Enterprise Inc stock at Purchase.

Sales and Margin forecast 2026, 2027 to 2030

Sign up for free to unlock analyst estimates. Sign up for free

Select at least one metric to display the chart.


Dec '25 2026
Estimates
Revenue Billion $ ??? ???
??? ???
EBITDA Margin ??? ???
??? ???
Net Margin ??? ???
??? ???

23 Analysts have issued a sales forecast Axon Enterprise Inc 2026 . The average Axon Enterprise Inc sales estimate is

. This is than the revenue of the last 12 months(TTM). The highest sales forecast is , the lowest is .

This results in the following potential growth metrics:

Revenue Estimates

2025 $2.8b 33.47%
2026
2027
2028
2029
2030

22 Analysts have issued an Axon Enterprise Inc EBITDA forecast 2026. The average Axon Enterprise Inc EBITDA estimate is

. This is than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is , the lowest is .

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2025 $51.0m 54.34%
2026
2027
2028

EBITDA Margin

2025 1.83% 65.79%
2026
2027
2028

25 Axon Enterprise Inc Analysts have issued a net profit forecast 2026. The average Axon Enterprise Inc net profit estimate is

. This is than the net profit for the last 12 months(TTM). The highest net profit forecast is , the lowest is .

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2025 $125m 66.94%
2026
2027
2028

Net Margin

2025 4.48% 75.23%
2026
2027
2028

Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2030

Sign up for free to unlock analyst estimates. Sign up for free

Select at least one metric to display the chart.


Dec '25 2026
Estimates
Earnings Per Share $ ??? ???
??? ???
P/E ???
EV/Sales ???

25 Analysts have issued a Axon Enterprise Inc forecast for earnings per share. The average Axon Enterprise Inc EPS is

. This is than earnings per share in the financial year 2025. The highest EPS forecast is , the lowest is .

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2025 $1.51 68.54%
2026
2027
2028

P/E ratio

Current 181.76 1.95%
2026
2027
2028

Based on analysts' sales estimates for 2026, the Axon Enterprise Inc stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 11.38 52.70%
2026
2027
2028
2029
2030

P/S ratio

Current 11.05 54.24%
2026
2027
2028
2029
2030

Current Axon Enterprise Inc Upgrades & Downgrades

Analyst Rating Action Date
TD Cowen
Buy
➜
Buy
Unchanged Oct 26 2026
Piper Sandler
Overweight
➜
Overweight
Unchanged Oct 20 2026
Argus Research
Buy
➜
Buy
Unchanged Sep 03 2026
Piper Sandler
Overweight
➜
Overweight
Unchanged Aug 06 2026
Morgan Stanley
Overweight
➜
Overweight
Unchanged Aug 06 2026
UBS
Neutral
➜
Neutral
Unchanged Aug 06 2026
Barclays
Overweight
➜
Overweight
Unchanged Aug 06 2026
Analyst Rating Date
Unchanged
TD Cowen:
Buy
➜
Buy
Oct 26 2026
Unchanged
Piper Sandler:
Overweight
➜
Overweight
Oct 20 2026
Unchanged
Argus Research:
Buy
➜
Buy
Sep 03 2026
Unchanged
Piper Sandler:
Overweight
➜
Overweight
Aug 06 2026
Unchanged
Morgan Stanley:
Overweight
➜
Overweight
Aug 06 2026
Unchanged
UBS:
Neutral
➜
Neutral
Aug 06 2026
Unchanged
Barclays:
Overweight
➜
Overweight
Aug 06 2026

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today